Publication Information

{'id': 'https://openalex.org/W2033131456', 'doi': 'https://doi.org/10.1021/bi7023157', 'title': 'Crystal Structures of Highly Constrained Substrate and Hydrolysis Products Bound to HIV-1 Protease. Implications for the Catalytic Mechanism', 'display_name': 'Crystal Structures of Highly Constrained Substrate and Hydrolysis Products Bound to HIV-1 Protease. Implications for the Catalytic Mechanism', 'publication_year': 2008, 'publication_date': '2008-03-01', 'ids': {'openalex': 'https://openalex.org/W2033131456', 'doi': 'https://doi.org/10.1021/bi7023157', 'mag': '2033131456', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/18311928'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/bi7023157', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S104038378', 'display_name': 'Biochemistry', 'issn_l': '0006-2960', 'issn': ['0006-2960', '1520-4995', '1943-295X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5036498123', 'display_name': 'Joel D. A. Tyndall', 'orcid': 'https://orcid.org/0000-0003-0783-1635'}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Joel D. A. Tyndall', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026408906', 'display_name': 'Leonard K. Pattenden', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Leonard K. Pattenden', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021768732', 'display_name': 'Robert C. Reid', 'orcid': 'https://orcid.org/0000-0002-0829-239X'}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Robert C. Reid', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103084982', 'display_name': 'Shuhong Hu', 'orcid': 'https://orcid.org/0000-0002-3878-1469'}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Shu-Hong Hu', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060611076', 'display_name': 'Dianne Alewood', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Dianne Alewood', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058316270', 'display_name': 'Paul F. Alewood', 'orcid': 'https://orcid.org/0000-0001-7454-6522'}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Paul F. Alewood', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103819925', 'display_name': 'Terry Walsh', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Terry Walsh', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053439487', 'display_name': 'David P. Fairlie', 'orcid': 'https://orcid.org/0000-0002-7856-8566'}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'David P. Fairlie', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5040201335', 'display_name': 'Jennifer L. Martin', 'orcid': 'https://orcid.org/0000-0002-9225-8863'}, 'institutions': [{'id': 'https://openalex.org/I80281795', 'display_name': 'University of Otago', 'ror': 'https://ror.org/01jmxt844', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I80281795']}, {'id': 'https://openalex.org/I160993911', 'display_name': 'Queensland University of Technology', 'ror': 'https://ror.org/03pnv4752', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I160993911']}, {'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}], 'countries': ['AU', 'NZ'], 'is_corresponding': False, 'raw_author_name': 'Jennifer L. Martin', 'raw_affiliation_strings': ['National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia'], 'affiliations': [{'raw_affiliation_string': 'National School of Pharmacy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand, Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia, and Centre for Molecular Biotechnology, Queensland University of Technology, Brisbane QLD 4001, Australia', 'institution_ids': ['https://openalex.org/I80281795', 'https://openalex.org/I160993911', 'https://openalex.org/I165143802']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.94, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 22, 'citation_normalized_percentile': {'value': 0.709261, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 88, 'max': 89}, 'biblio': {'volume': '47', 'issue': '12', 'first_page': '3736', 'last_page': '3744'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9956, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11162', 'display_name': 'Enzyme Structure and Function', 'score': 0.9884, 'subfield': {'id': 'https://openalex.org/subfields/2505', 'display_name': 'Materials Chemistry'}, 'field': {'id': 'https://openalex.org/fields/25', 'display_name': 'Materials Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2776714187', 'wikidata': 'https://www.wikidata.org/wiki/Q212410', 'display_name': 'Protease', 'level': 3, 'score': 0.76124185}, {'id': 'https://openalex.org/C94412978', 'wikidata': 'https://www.wikidata.org/wiki/Q103135', 'display_name': 'Hydrolysis', 'level': 2, 'score': 0.673787}, {'id': 'https://openalex.org/C161790260', 'wikidata': 'https://www.wikidata.org/wiki/Q82264', 'display_name': 'Catalysis', 'level': 2, 'score': 0.609779}, {'id': 'https://openalex.org/C89611455', 'wikidata': 'https://www.wikidata.org/wiki/Q6804646', 'display_name': 'Mechanism (biology)', 'level': 2, 'score': 0.60000455}, {'id': 'https://openalex.org/C2777289219', 'wikidata': 'https://www.wikidata.org/wiki/Q7632154', 'display_name': 'Substrate (aquarium)', 'level': 2, 'score': 0.5666027}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5529947}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.5213148}, {'id': 'https://openalex.org/C2994592520', 'wikidata': 'https://www.wikidata.org/wiki/Q5090496', 'display_name': 'Substrate specificity', 'level': 3, 'score': 0.41745144}, {'id': 'https://openalex.org/C21951064', 'wikidata': 'https://www.wikidata.org/wiki/Q899212', 'display_name': 'Combinatorial chemistry', 'level': 1, 'score': 0.3643693}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.36210525}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.28758258}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.21471813}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.17608821}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.09799066}, {'id': 'https://openalex.org/C18903297', 'wikidata': 'https://www.wikidata.org/wiki/Q7150', 'display_name': 'Ecology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C62520636', 'wikidata': 'https://www.wikidata.org/wiki/Q944', 'display_name': 'Quantum mechanics', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D016333', 'descriptor_name': 'HIV Protease', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D016333', 'descriptor_name': 'HIV Protease', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D001667', 'descriptor_name': 'Binding, Competitive', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002384', 'descriptor_name': 'Catalysis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016333', 'descriptor_name': 'HIV Protease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006860', 'descriptor_name': 'Hydrogen Bonding', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008958', 'descriptor_name': 'Models, Molecular', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008968', 'descriptor_name': 'Molecular Conformation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/bi7023157', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S104038378', 'display_name': 'Biochemistry', 'issn_l': '0006-2960', 'issn': ['0006-2960', '1520-4995', '1943-295X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/18311928', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.84}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 48, 'referenced_works': ['https://openalex.org/W1539796472', 'https://openalex.org/W1965349185', 'https://openalex.org/W1969741689', 'https://openalex.org/W1969788448', 'https://openalex.org/W1975914851', 'https://openalex.org/W1976482662', 'https://openalex.org/W1979853120', 'https://openalex.org/W1984492947', 'https://openalex.org/W1985469117', 'https://openalex.org/W1986191025', 'https://openalex.org/W1986853728', 'https://openalex.org/W1991448988', 'https://openalex.org/W1991696252', 'https://openalex.org/W1992636402', 'https://openalex.org/W1994426933', 'https://openalex.org/W1996607909', 'https://openalex.org/W1997319983', 'https://openalex.org/W2013083986', 'https://openalex.org/W2015473272', 'https://openalex.org/W2015492400', 'https://openalex.org/W2018171280', 'https://openalex.org/W2022251488', 'https://openalex.org/W2023722477', 'https://openalex.org/W2030402747', 'https://openalex.org/W2035690849', 'https://openalex.org/W2043560498', 'https://openalex.org/W2051881223', 'https://openalex.org/W2052696994', 'https://openalex.org/W2056005890', 'https://openalex.org/W2058155604', 'https://openalex.org/W2060448324', 'https://openalex.org/W2060879531', 'https://openalex.org/W2061418366', 'https://openalex.org/W2066657190', 'https://openalex.org/W2069961994', 'https://openalex.org/W2071313480', 'https://openalex.org/W2079830607', 'https://openalex.org/W2080237955', 'https://openalex.org/W2080878445', 'https://openalex.org/W2091510843', 'https://openalex.org/W2093751313', 'https://openalex.org/W2102073045', 'https://openalex.org/W2105175831', 'https://openalex.org/W2107005517', 'https://openalex.org/W2114367386', 'https://openalex.org/W2131046434', 'https://openalex.org/W2168918508', 'https://openalex.org/W2951811260'], 'related_works': ['https://openalex.org/W314815708', 'https://openalex.org/W2587733587', 'https://openalex.org/W2379938146', 'https://openalex.org/W2361364942', 'https://openalex.org/W2355642964', 'https://openalex.org/W2117340465', 'https://openalex.org/W2046536786', 'https://openalex.org/W1983970916', 'https://openalex.org/W1981911623', 'https://openalex.org/W1969181144'], 'abstract_inverted_index': {'HIV-1': [0, 57], 'protease': [1, 58, 262], 'is': [2, 179, 185], 'a': [3, 31, 37, 85], 'key': [4], 'target': [5], 'in': [6, 84, 112, 142, 146, 207, 260], 'treating': [7], 'HIV': [8], 'infection': [9], 'and': [10, 59, 65, 137, 165, 188], 'AIDS,': [11], 'with': [12, 53], '10': [13], 'inhibitors': [14, 245], 'used': [15, 19], 'clinically.': [16], 'Here': [17], 'we': [18], 'an': [20, 60, 80, 208, 213], 'unusual': [21, 214], 'hexapeptide': [22], 'substrate,': [23], 'containing': [24], 'two': [25, 107, 117], 'macrocyclic': [26], 'tripeptides': [27], 'constrained': [28], 'to': [29, 41, 126, 168, 269], 'mimic': [30], 'β': [32], 'strand': [33], 'conformation,': [34], 'linked': [35], 'by': [36, 236], 'scissile': [38], 'peptide': [39, 95], 'bond,': [40], 'probe': [42], 'the': [43, 75, 91, 102, 113, 120, 132, 138, 143, 147, 160, 169, 182, 232, 247, 251, 258, 261, 270], 'structural': [44], 'mechanism': [45, 234], 'of': [46, 74, 93, 97, 101, 119, 177, 228, 244, 250, 257], 'proteolysis.': [47], 'The': [48, 72, 99, 150, 200, 222, 238], 'substrate': [49, 82, 193], 'has': [50], 'been': [51], 'cocrystallized': [52], 'catalytically': [54], 'active': [55, 103, 114, 161], 'synthetic': [56], 'inactive': [61, 76], 'isosteric': [62], '(D25N)': [63], 'mutant,': [64], 'three-dimensional': [66], 'structures': [67, 172], 'were': [68], 'determined': [69], '(1.60': [70], 'Å).': [71], 'structure': [73, 100], 'HIVPR(D25N)/substrate': [77], 'complex': [78, 105, 202, 217], 'shows': [79, 106], 'intact': [81], 'molecule': [83, 130], 'single': [86], 'orientation': [87, 227], 'that': [88, 153, 174, 181, 189, 264], 'perfectly': [89], 'mimics': [90], 'binding': [92, 141, 176], 'conventional': [94], 'ligands': [96, 178], 'HIVPR.': [98], 'HIVPR/product': [104], 'monocyclic': [108, 122], 'hydrolysis': [109, 155], 'products': [110, 156], 'trapped': [111], 'site,': [115, 134], 'revealing': [116], 'molecules': [118], 'N-terminal': [121, 175, 248], 'product': [123, 201], 'bound': [124], 'adjacent': [125], 'one': [127, 129], 'another,': [128], 'occupying': [131], 'nonprime': [133], 'as': [135], 'expected,': [136], 'other': [139], 'monocycle': [140], 'prime': [144], 'site': [145, 162, 184, 253], 'reverse': [148], 'orientation.': [149], 'results': [151, 239], 'suggest': [152], 'both': [154], 'are': [157], 'released': [158], 'from': [159], 'upon': [163], 'cleavage': [164, 233, 252, 271], 'then': [166], 'rebind': [167], 'enzyme.': [170], 'These': [171], 'reveal': [173], 'preferred,': [180], 'C-terminal': [183, 268], 'more': [186], 'flexible,': [187], 'HIVPR': [190], 'can': [191], 'recognize': [192], 'shape': [194], 'rather': [195], 'than': [196], 'just': [197], 'sequence': [198], 'alone.': [199], 'reveals': [203], 'three': [204, 219], 'carboxylic': [205, 220], 'acids': [206], 'almost': [209], 'planar': [210], 'orientation,': [211], 'indicating': [212], 'hexagonal': [215], 'homodromic': [216], 'between': [218], 'acids.': [221], 'data': [223], 'presented': [224], 'herein': [225], 'regarding': [226], 'catalytic': [229], 'aspartates': [230], 'support': [231], 'proposed': [235], 'Northrop.': [237], 'imply': [240], 'strategies': [241], 'for': [242], 'design': [243], 'targeting': [246], 'side': [249], 'or': [254], 'taking': [255], 'advantage': [256], 'flexibility': [259], 'domain': [263], 'accommodates': [265], 'substrate/inhibitor': [266], 'segments': [267], 'site.': [272]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2033131456', 'counts_by_year': [{'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 4}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-22T06:01:08.533061', 'created_date': '2016-06-24'}